Merck & Co has announced its acquisition of cancer research biotech ArQule in a $2.7 billion deal.
Sanofi is to acquire Synthorx, a biotechnology company focused on improving the lives of people suffering from cancer and autoimmune diseases, for $2.5 billion.
California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.
DLA Piper has strengthened its San Francisco office with the addition of a former Arnold & Porter Kaye Scholer counsel.
The best lawyers acting for life sciences companies make sure they fully understand their clients’ business models, said in-house counsel at Life Sciences Patent Network 2019.
The US Department of Justice has charged a former Monsanto employee with committing economic espionage and trade secrets theft.
The team leader behind the world’s first artificial intelligence-generated patent application has said AI inventors will force major changes to the patent system.
Switzerland-based Roche has agreed to acquire Promedior and its portfolio of molecules for serious fibrotic diseases.
The Regents of the University of Michigan have sued an optical microscope manufacturer for allegedly infringed one of its patents.
Seattle Genetics has asked the American Arbitration Association to help resolve a dispute with Daiichi Sankyo, alleging that the Japanese pharma company used its technology to create a number of drugs.